|
|
|
|
|
| Prospectus synopsis |
| |
|
|
Phone:+91 22 4973 1411/+91 22 4973 1419 Fax:
|
| Initial public issue of up to 22,41,000 equity shares of face value of Rs.10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores ("Public Isue") out of which upto 1,13,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.33 % and 25 %, respectively of the post-issue paid-up equity share capital of the company.
Price Band: Rs. 115 to Rs. 123 per equity share of face value of Rs. 10 each.
The floor price is 11.5 times of the face value and the cap price is 12.3 times of the face value.
Bids can be made for the minimum of 1000 equity shares and in multiples of 1000 equity shares thereafter.
|
| 09-Jul-25 |
11-Jul-25 |
Rs
115.00-123.00
|
Rs
0.00-0.00
|
| Minimum Application for shares in Nos :
1000
Further Multiples of :
1000
|
| Project Cost |
0.00 |
| Sobhagya Capital Options Pvt. Ltd. |
|
| Project Financed through Current Offer |
25.77 |
|
| Post Issue Equity Share Capital |
8.51 |
|
| Issue Price |
Rs.115.00
|
|
|
|
|
| |
|
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
|
Funding the incremental working capital requirements of our company
|
|
Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.
|
General corporate purposes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|